49665-3
HIV susceptibility panel by Phenotype method
Active
49664-6 HIV reverse transcriptase susceptibility panel by Phenotype method
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- HIV reverse transcriptase susceptibility panel
- Property
- -
- Time
- Pt
- System
- Isolate
- Scale
- -
- Method
- Phenotyping
Additional Names
- Short Name
- HIV RT Susc Pnl Islt Phenotyp
- Display Name
- HIV reverse transcriptase susceptibility panel Phenotype method (Isol)
- Consumer Name Alpha Get Info
- HIV reverse transcriptase susceptibility panel
Basic Attributes
- Class
- PANEL.ABXBACT
- Type
- Laboratory
- First Released
- Version 2.22
- Last Updated
- Version 2.73
- Order vs. Observation
- Subset
- Common Test Rank Get Info
- 18285
- Panel Type
- Panel
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Panel de susceptibilidad a la transcriptasa inversa del VIH: |
| es-ES | Spanish (Spain) | Mutaciones en la transcriptasa inversa de HIV: |
| fr-FR | French (France) | VIH reverse transcriptase sensibilité panel: |
| fr-BE | French (Belgium) | HIV. Reverse transcriptase . Mutations: Synonyms: HIV |
| it-IT | Italian (Italy) | HIV, mutazioni trascrittasi inversa: Synonyms: Mutazioni della trascrittasi inversa dell''HIV Punto nel tempo (episodio) Set di prescrizione per suscettibilità Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | HIV reverse transcriptase mutaties: |
| pl-PL | Polish (Poland) | HIV panel wrażliwości na inhibitory odwrotnej transkryptazy: Synonyms: Panel wrażliwości ludzkiego wirusa niedoboru odporności na inhibitory odwrotnej transkryptazy |
| pt-BR | Portuguese (Brazil) | HIV protease mutações do gene: Synonyms: ; |
| zh-CN | Chinese (China) | HIV 逆转录酶敏感性组套: Synonyms: AIDS; |
49663-8 HIV nucleoside reverse transcriptase susceptibility panel by Phenotype method
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- HIV nucleoside reverse transcriptase susceptibility panel
- Property
- -
- Time
- Pt
- System
- Isolate
- Scale
- -
- Method
- Phenotyping
Additional Names
- Short Name
- HIV NRTI Susc Pnl Islt Phenotyp
- Display Name
- HIV nucleoside reverse transcriptase susceptibility panel Phenotype method (Isol)
- Consumer Name Alpha Get Info
- HIV nucleoside reverse transcriptase susceptibility panel
Basic Attributes
- Class
- PANEL.ABXBACT
- Type
- Laboratory
- First Released
- Version 2.22
- Last Updated
- Version 2.52
- Order vs. Observation
- Subset
- Panel Type
- Panel
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Panel de susceptibilidad a la transcriptasa inversa de nucleósidos del VIH: |
| es-ES | Spanish (Spain) | Mutaciones nucleotídica de transcriptasa inversa de HIV: |
| fr-FR | French (France) | VIH reverse transcriptase nucléosidique sensibilité panel: |
| fr-BE | French (Belgium) | HIV. Reverse transcriptase . Mutations nucléoside: Synonyms: HIV |
| it-IT | Italian (Italy) | HIV, mutazioni nucleosidiche trascrittasi inversa: Synonyms: Mutazioni nucleosidiche della trascrittasi inversa Punto nel tempo (episodio) Set di prescrizione per suscettibilità Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | HIV nucleoside reverse transcriptase mutaties: |
| pl-PL | Polish (Poland) | HIV panel wrażliwości na nukleozydowe inhibitory odwrotnej transkryptazy: Synonyms: Panel wrażliwości ludzkiego wirusa niedoboru odporności na nukleozydowe inhibitory odwrotnej transkryptazy |
| pt-BR | Portuguese (Brazil) | HIV nucleosídeos mutações da transcriptase reversa: Synonyms: ; |
| zh-CN | Chinese (China) | HIV 核苷逆转录酶敏感性组套: Synonyms: AIDS; |
30273-7 Abacavir [Susceptibility] by Phenotype method
Part Descriptions
LP21306-3 Abacavir
Abacavir (ABC) is a Nucleoside Reverse Transcriptase Inhibitor(NRTI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Abacavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Abacavir Islt Phenotyp
- Display Name
- Abacavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Abacavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 17878
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41243-3 | AbacavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Abacavir: |
| es-MX | Spanish (Mexico) | Abacavir: |
| es-AR | Spanish (Argentina) | abacavir: |
| es-ES | Spanish (Spain) | Abacavir: |
| et-EE | Estonian (Estonia) | Abakaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Abacavir: |
| fr-FR | French (France) | Abacavir: |
| fr-BE | French (Belgium) | Abacavir: |
| it-IT | Italian (Italy) | Abacavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 아바카비어: |
| nl-NL | Dutch (Netherlands) | abacavir: |
| pt-BR | Portuguese (Brazil) | Abacavir: Synonyms: Ziagen; |
| tr-TR | Turkish (Turkey) | Abakavir: Synonyms: Abakavir |
| zh-CN | Chinese (China) | 阿巴卡韦: Synonyms: Abacavir Sulfate; |
30270-3 Didanosine [Susceptibility] by Phenotype method
Part Descriptions
LP21309-7 Didanosine
A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite.
Source: National Library of Medicine, MeSH 2006
LP21309-7 Didanosine
Didanosine is a Nucleoside Reverse Transcriptase Inhibitor(NRTI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Didanosine
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Didanosine Islt Phenotyp
- Display Name
- Didanosine Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Didanosine
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 19901
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41240-9 | DidanosineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Didanosin: |
| es-MX | Spanish (Mexico) | Didanosina: |
| es-AR | Spanish (Argentina) | didanosina: |
| es-ES | Spanish (Spain) | Didanosina: |
| et-EE | Estonian (Estonia) | Didanosiin: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Didanosine: |
| fr-FR | French (France) | Didanosine: |
| fr-BE | French (Belgium) | Didanosine: |
| it-IT | Italian (Italy) | Didanosina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 디다노신: |
| nl-NL | Dutch (Netherlands) | didanosine: |
| pt-BR | Portuguese (Brazil) | Didanosina: Synonyms: Videx; |
| tr-TR | Turkish (Turkey) | Didanozin: |
| zh-CN | Chinese (China) | 去羟肌苷: Synonyms: ddI; |
49669-5 Emtricitabine [Susceptibility] by Phenotype method
Part Descriptions
LP35786-0 Emtricitabine
Emtricitabine is an antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
LP35786-0 Emtricitabine
Emtricitabine (FTC), with trade name Emtriva (formerly Coviracil), is a nucleoside reverse transcriptase inhibitor (NRTI) for the treatment of HIV infection in adults and children.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Emtricitabine
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Emtricitabine Islt Phenotyp
- Display Name
- Emtricitabine Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Emtricitabine
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.22
- Last Updated
- Version 2.22
- Order vs. Observation
- Both
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41269-8 | EmtricitabineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Emtricitabina: |
| es-ES | Spanish (Spain) | Emtricitabina: |
| et-EE | Estonian (Estonia) | Emtritsitabiin: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Emtricitabine: |
| fr-FR | French (France) | Emtricitabine: |
| fr-BE | French (Belgium) | Emtricitabine: |
| it-IT | Italian (Italy) | Emtricitabina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | emtricitabine: |
| pt-BR | Portuguese (Brazil) | Emtricitabine: Synonyms: Emtriva; |
| tr-TR | Turkish (Turkey) | Emtrisitabin: |
| zh-CN | Chinese (China) | 恩曲他滨: Synonyms: FTC 分离物; |
30269-5 lamiVUDine [Susceptibility] by Phenotype method
Part Descriptions
LP21312-1 lamiVUDine
Lamivudine is a Nucleoside Reverse Transcriptase Inhibitor(NRTI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
LP21312-1 lamiVUDine
Lamivudine (2',3'-dideoxy-3'-thiacytidine, commonly called 3TC) is a potent nucleoside analog reverse transcriptase inhibitor (nRTI).
Lamivudine has been used for treatment of chronic hepatitis B at a lower dose than for treatment of HIV. It improves the seroconversion of e-antigen positive hepatitis B and also improves histology staging of the liver. Long term use of lamivudine unfortunately leads to emergence of a resistant hepatitis B virus (YMDD) mutant. Despite this, lamivudine is still used widely as it is well tolerated.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- lamiVUDine
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- lamiVUDine Islt Phenotyp
- Display Name
- lamiVUDine Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to lamiVUDine
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.19
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41239-1 | LamivudineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Lamivudin: |
| es-MX | Spanish (Mexico) | lamiVUDine: |
| es-AR | Spanish (Argentina) | lamivudina: |
| es-ES | Spanish (Spain) | Lamivudina: |
| et-EE | Estonian (Estonia) | Lamivudiin: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Lamivudine: Synonyms: #REF! |
| fr-FR | French (France) | Lamivudine: |
| fr-BE | French (Belgium) | Lamivudine: |
| it-IT | Italian (Italy) | Lamivudina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 라미부딘: |
| nl-NL | Dutch (Netherlands) | lamivudine: |
| pt-BR | Portuguese (Brazil) | Lamivudine: Synonyms: Epivir; |
| tr-TR | Turkish (Turkey) | Lamivudin: |
| zh-CN | Chinese (China) | 拉米夫定: Synonyms: 3TC; |
30272-9 Stavudine [Susceptibility] by Phenotype method
Part Descriptions
LP21315-4 Stavudine
A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.
Source: National Library of Medicine, MeSH 2006
LP21315-4 Stavudine
Stavudine (2'-3'-didehydro-2'-3'-dideoxythymidine, d4T, brand name Zerit) is a nucleoside analog reverse transcriptase inhibitor (NARTI) active against HIV.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Stavudine
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Stavudine Islt Phenotyp
- Display Name
- Stavudine Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Stavudine
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 18163
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41242-5 | StavudineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Stavudine: |
| es-AR | Spanish (Argentina) | estavudina: |
| es-ES | Spanish (Spain) | Estavudina: |
| et-EE | Estonian (Estonia) | Stavudiin: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Stavudine: |
| fr-FR | French (France) | Stavudine: |
| fr-BE | French (Belgium) | Stavudine: |
| it-IT | Italian (Italy) | Stavudina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 스타부딘: |
| nl-NL | Dutch (Netherlands) | stavudine: |
| pt-BR | Portuguese (Brazil) | Stavudina: Synonyms: Zerit; |
| tr-TR | Turkish (Turkey) | Stavudin: |
| zh-CN | Chinese (China) | 司他夫定: Synonyms: d4T 分离物; |
34644-5 Tenofovir [Susceptibility] by Phenotype method
Part Descriptions
LP28761-2 Tenofovir
Tenofovir is an antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
LP28761-2 Tenofovir
Tenofovir disoproxil fumarate (TDF or PMPA), marketed as Viread, belongs to a class of antiretroviral drugs known as nucleotide analogue reverse transcriptase inhibitors (NRTIs), which block reverse transcriptase, an enzyme crucial to viral production.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Tenofovir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Tenofovir Islt Phenotyp
- Display Name
- Tenofovir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Tenofovir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.11
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 18210
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41218-5 | TenofovirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Tenofovir: |
| es-AR | Spanish (Argentina) | tenofovir: |
| es-ES | Spanish (Spain) | Tenofovir: |
| et-EE | Estonian (Estonia) | Tenofoviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Ténofovir: |
| fr-FR | French (France) | Ténofovir: |
| fr-BE | French (Belgium) | Ténofovir: |
| it-IT | Italian (Italy) | Tenofovir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 테노포비어: |
| nl-NL | Dutch (Netherlands) | tenofovir: |
| pt-BR | Portuguese (Brazil) | Tenofovir: Synonyms: Viread; |
| tr-TR | Turkish (Turkey) | Tenofovir: |
| zh-CN | Chinese (China) | 替诺福韦: Synonyms: DF; |
30268-7 Zidovudine [Susceptibility] by Phenotype method
Part Descriptions
LP16744-2 Zidovudine
Zidovudine is a Nucleoside Reverse Transcriptase Inhibitor(NRTI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
LP16744-2 Zidovudine
Zidovudine (INN) or azidothymidine (AZT) (also called ZDV) is a nucleoside analog reverse-transcriptase inhibitor (NRTI), a type of antiretroviral drug used for the first clinically proven successful treatment of HIV/AIDS infectiousness.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Zidovudine
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Zidovudine Islt Phenotyp
- Display Name
- Zidovudine Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Zidovudine
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 18454
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41238-3 | ZidovudineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Zidovudin: |
| es-MX | Spanish (Mexico) | Zidovudina: |
| es-AR | Spanish (Argentina) | zidovudina: |
| es-ES | Spanish (Spain) | Zidovudina: |
| et-EE | Estonian (Estonia) | Tsidovudiin: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Zidovudine: |
| fr-FR | French (France) | Zidovudine: |
| fr-BE | French (Belgium) | Zidovudine: |
| it-IT | Italian (Italy) | Zidovudina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 지도부딘: |
| nl-NL | Dutch (Netherlands) | zidovudine: |
| pt-BR | Portuguese (Brazil) | Zidovudina: Synonyms: ZDV; |
| tr-TR | Turkish (Turkey) | Zidovudine: |
| zh-CN | Chinese (China) | 齐多夫定: Synonyms: AZT; |
49662-0 HIV nonnucleoside reverse transcriptase susceptibility panel by Phenotype method
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- HIV nonnucleoside reverse transcriptase susceptibility panel
- Property
- -
- Time
- Pt
- System
- Isolate
- Scale
- -
- Method
- Phenotyping
Additional Names
- Short Name
- HIV NNRTI Susc Pnl Islt Phenotyp
- Display Name
- HIV nonnucleoside reverse transcriptase susceptibility panel Phenotype method (Isol)
- Consumer Name Alpha Get Info
- HIV nonnucleoside reverse transcriptase susceptibility panel
Basic Attributes
- Class
- PANEL.ABXBACT
- Type
- Laboratory
- First Released
- Version 2.22
- Last Updated
- Version 2.52
- Order vs. Observation
- Subset
- Panel Type
- Panel
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Panel de susceptibilidad a la transcriptasa inversa no nucleósida del VIH: |
| es-ES | Spanish (Spain) | Mutaciones no nucleotídica de transcriptasa inversa de HIV: |
| fr-FR | French (France) | VIH résistance aux Inhibiteurs non nucléos(t)idiques panel: |
| fr-BE | French (Belgium) | HIV. Reverse transcriptase . Mutations nonnucléoside: Synonyms: HIV |
| it-IT | Italian (Italy) | HIV, mutazioni non nucleosidiche trascrittasi inversa: Synonyms: Mutazioni non nucleosidiche della trascrittasi inv Punto nel tempo (episodio) Set di prescrizione per suscettibilità Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | HIV nonnucleoside reverse transcriptase mutaties: |
| pl-PL | Polish (Poland) | HIV panel wrażliwości na nienukleozydowe inhibitory odwrotnej transkryptazy: Synonyms: Panel wrażliwości ludzkiego wirusa niedoboru odporności na nienukleozydowe inhibitory odwrotnej transkryptazy |
| pt-BR | Portuguese (Brazil) | HIV mutações da transcriptase reversa não-nucleosídeo: Synonyms: ; |
| zh-CN | Chinese (China) | HIV 非核苷逆转录酶敏感性组套: Synonyms: AIDS; |
30276-0 Delavirdine [Susceptibility] by Phenotype method
Part Descriptions
LP21173-7 Delavirdine
A potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1.
Source: National Library of Medicine, MeSH 2006
LP21173-7 Delavirdine
Delavirdine is a Nonnucleoside Reverse Transcriptase Inhibitor (Non-NRTI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Delavirdine
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Delavirdine Islt Phenotyp
- Display Name
- Delavirdine Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Delavirdine
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.19
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41246-6 | DelavirdineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Delavirdin: |
| es-MX | Spanish (Mexico) | Delavirdina: |
| es-AR | Spanish (Argentina) | delavirdina: |
| es-ES | Spanish (Spain) | Delavirdina: |
| et-EE | Estonian (Estonia) | Delavirdiin: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Délavirdine: |
| fr-FR | French (France) | Delavirdine: |
| fr-BE | French (Belgium) | Délavirdine: |
| it-IT | Italian (Italy) | Delavirdina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 델라비르딘: |
| nl-NL | Dutch (Netherlands) | delavirdine: |
| pt-BR | Portuguese (Brazil) | Delavirdina: Synonyms: Rescriptor; |
| tr-TR | Turkish (Turkey) | Delavirdin: |
| zh-CN | Chinese (China) | 地拉韦定: Synonyms: Dlv; |
30277-8 Efavirenz [Susceptibility] by Phenotype method
Part Descriptions
LP21310-5 Efavirenz
Efavirenz is a Nonnucleoside Reverse Transcriptase Inhibitor (Non-NRTI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
LP21310-5 Efavirenz
Efavirenz (EFV, brand names Sustiva and Stocrin) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is used as part of highly active antiretroviral therapy (HAART) for the treatment of a human immunodeficiency virus (HIV) type 1.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Efavirenz
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Efavirenz Islt Phenotyp
- Display Name
- Efavirenz Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Efavirenz
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 19676
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41247-4 | EfavirenzSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Efavirenz: |
| es-MX | Spanish (Mexico) | Efavirenz: |
| es-AR | Spanish (Argentina) | efavirenz: |
| es-ES | Spanish (Spain) | Efavirenz: |
| fr-CA | French (Canada) | Éfavirenz: |
| fr-FR | French (France) | Éfavirenz: |
| fr-BE | French (Belgium) | Éfavirenz: |
| it-IT | Italian (Italy) | Efavirenz: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 에파비렌즈: |
| nl-NL | Dutch (Netherlands) | efavirenz: |
| pt-BR | Portuguese (Brazil) | Efavirenz: Synonyms: Sustiva; |
| tr-TR | Turkish (Turkey) | Efavirenz: |
| zh-CN | Chinese (China) | 依法韦恩茨: Synonyms: EFV; |
72558-0 Etravirine [Susceptibility] by Phenotype method
Part Descriptions
LP68431-3 Etravirine
Etravirine (brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTIs). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etravirine. Etravirine is marketed by Tibotec, a subsidiary of Johnson & Johnson. In January 2008, the Food and Drug Administration approved its use for patients with established resistance to other drugs, making it the 30th anti-HIV drug approved in the United States and the first to be approved in 2008. It was also approved for use in Canada on April 1, 2008.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Etravirine
LP68431-3 Etravirine
Etravirine (ETR) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Fully-Specified Name
- Component
- Etravirine
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Etravirine Islt Phenotyp
- Display Name
- Etravirine Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Etravirine
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.42
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 19596
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41387-8 | EtravirineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Etravirina: |
| es-ES | Spanish (Spain) | Etravirina: |
| et-EE | Estonian (Estonia) | Etraviriin: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Etravirine: |
| fr-FR | French (France) | Étravirine: |
| fr-BE | French (Belgium) | Etravirine: |
| it-IT | Italian (Italy) | Etravirina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | etravirine: |
| pt-BR | Portuguese (Brazil) | Etravirine: |
| tr-TR | Turkish (Turkey) | Etravirin: |
| zh-CN | Chinese (China) | 依曲韦林: Synonyms: Intelence; |
30275-2 Nevirapine [Susceptibility] by Phenotype method
Part Descriptions
LP21317-0 Nevirapine
Nevirapine is a Nonnucleoside Reverse Transcriptase Inhibitor (Non-NRTI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
LP21317-0 Nevirapine
Nevirapine, also marketed under the trade name Viramune (Boehringer Ingelheim), is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS.
As with other antiretroviral drugs, HIV rapidly develops resistance if nevirapine is used alone, so recommended therapy consists of combinations of three or more antiretrovirals.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Nevirapine
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Nevirapine Islt Phenotyp
- Display Name
- Nevirapine Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Nevirapine
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 19321
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41245-8 | NevirapineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Nevirapina: |
| es-AR | Spanish (Argentina) | nevirapina: |
| es-ES | Spanish (Spain) | Nevirapina: |
| et-EE | Estonian (Estonia) | Nevirapiin: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Névirapine: |
| fr-FR | French (France) | Névirapine: |
| fr-BE | French (Belgium) | Névirapine: |
| it-IT | Italian (Italy) | Nevirapina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 네비라핀: |
| nl-NL | Dutch (Netherlands) | nevirapine: |
| pt-BR | Portuguese (Brazil) | Nevirapina: Synonyms: Viramune; |
| tr-TR | Turkish (Turkey) | Nevirapin: |
| zh-CN | Chinese (China) | 奈韦拉平: Synonyms: NVP 分离物; |
72557-2 Rilpivirine [Susceptibility] by Phenotype method
Part Descriptions
LP135443-2 Rilpivirine
Rilpivirine (brand name Edurant) is a pharmaceutical drug, developed by Tibotec, for the treatment of HIV infection. It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, http://en.wikipedia.org/wiki/Rilpivirine
Fully-Specified Name
- Component
- Rilpivirine
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Rilpivirine Islt Phenotyp
- Display Name
- Rilpivirine Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Rilpivirine
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.42
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 17396
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41382-9 | RilpivirineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Rilpivirina: |
| es-ES | Spanish (Spain) | Rilpivirina: |
| fr-CA | French (Canada) | Rilpivirine: |
| fr-FR | French (France) | Rilpivirine: |
| it-IT | Italian (Italy) | Rilpivirina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | rilpivirine: |
| pt-BR | Portuguese (Brazil) | Rilpivirine: |
| tr-TR | Turkish (Turkey) | Rilpivirin: |
| zh-CN | Chinese (China) | 利匹韦林: Synonyms: 4-[4-[4-[(E)-2-Cyanovinyl]-2,6-dimethylphenylamino]pyrimidin-2-ylamino]benzonitrile; |
72559-8 HIV integrase inhibitor susceptibility panel by Phenotype method
Fully-Specified Name
- Component
- HIV integrase inhibitor susceptibility panel
- Property
- -
- Time
- Pt
- System
- Isolate
- Scale
- -
- Method
- Phenotyping
Additional Names
- Short Name
- HIV INI Susc Pnl Islt Phenotyp
- Display Name
- HIV integrase inhibitor susceptibility panel Phenotype method (Isol)
- Consumer Name Alpha Get Info
- HIV integrase inhibitor susceptibility panel
Basic Attributes
- Class
- PANEL.ABXBACT
- Type
- Laboratory
- First Released
- Version 2.42
- Last Updated
- Version 2.63
- Change Reason
- Updated OrderObs value from "Both" to "Order"
- Order vs. Observation
- Order
- Panel Type
- Panel
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Panel de susceptibilidad al inhibidor de la integrasa del VIH: |
| es-ES | Spanish (Spain) | Mutaciones inhibidoras de la HIV integrasa: |
| fr-FR | French (France) | VIH sensibilité aux inhibiteurs de l'intégrase panel: |
| it-IT | Italian (Italy) | HIV, inibitori delle integrasi, mutazioni: Synonyms: Mutuazioni degli inibitori delle integrasi di HIV Punto nel tempo (episodio) Set di prescrizione per suscettibilità Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | HIV integrase remmer mutaties: |
| pl-PL | Polish (Poland) | HIV panel wrażliwości na inhibitory integrazy: Synonyms: Panel wrażliwości ludzkiego wirusa niedoboru odporności na inhibitory integrazy |
| pt-BR | Portuguese (Brazil) | HIV integrase inibidor mutação: |
| zh-CN | Chinese (China) | HIV 整合酶抑制剂敏感性组套: Synonyms: AIDS; |
61198-8 Raltegravir [Susceptibility] by Phenotype method
Part Descriptions
LP102418-3 Raltegravir
Raltegravir (MK-0518, brand name Isentress) is an antiretroviral drug used to treat HIV infection. It is the first of a new class of HIV drugs, the integrase inhibitors.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
LP102418-3 Raltegravir
Raltegravir (brand name ISENTRESS) is used in combination with other medications to treat human immunodeficiency virus (HIV) infection. Raltegravir is in a class of medications called HIV integrase strand transfer inhibitors. It works by slowing the spread of HIV in the body. Raltegravir does not cure HIV infection and may not prevent patients from developing HIV-related illnesses. Raltegravir does not prevent affected individuals from spreading HIV.
Source: PubMed Health, Raltegravir
Fully-Specified Name
- Component
- Raltegravir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Raltegravir Islt Phenotyp
- Display Name
- Raltegravir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Raltegravir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.34
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 18721
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41441-3 | RaltegravirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Raltegravir: |
| es-ES | Spanish (Spain) | Raltegravir: |
| et-EE | Estonian (Estonia) | Raltegraviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Raltégravir: |
| fr-FR | French (France) | Raltégravir: |
| it-IT | Italian (Italy) | Raltegravir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | raltegravir: |
| pt-BR | Portuguese (Brazil) | Raltegravir: |
| tr-TR | Turkish (Turkey) | Raltegravir: |
| zh-CN | Chinese (China) | 雷特拉韦: Synonyms: 分离物; |
49661-2 HIV protease gene mutations by Phenotype method
Part Descriptions
LP64743-5 HIV protease gene mutations
The protease gene and the reverse transcriptase gene of the viral genome are sequenced and mutations identified. Mutations at codons thought to be associated with drug resistance are analyzed and reported using drug resistance rules-based algorithms. Novel mutations may also be identified and reported. Information from ARUP. Laboratories.
Source: Regenstrief Institute
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- HIV protease gene mutations
- Property
- -
- Time
- Pt
- System
- Isolate
- Scale
- -
- Method
- Phenotyping
Additional Names
- Short Name
- HIV PI gene mut Islt Phenotyp
- Display Name
- HIV protease gene mutations Phenotype method (Isol)
- Consumer Name Alpha Get Info
- HIV protease gene mutations
Basic Attributes
- Class
- PANEL.ABXBACT
- Type
- Laboratory
- First Released
- Version 2.22
- Last Updated
- Version 2.73
- Order vs. Observation
- Subset
- Common Test Rank Get Info
- 16645
- Panel Type
- Panel
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Mutaciones del gen de la proteasa del VIH: |
| es-ES | Spanish (Spain) | Mutaciones en el gen de la proteasa de HIV: |
| fr-CA | French (Canada) | Gène de la protéase du VIH, Mutations: |
| fr-FR | French (France) | VIH gène protéase mutations: |
| fr-BE | French (Belgium) | HIV.gène protéase.mutations: Synonyms: HIV |
| it-IT | Italian (Italy) | HIV, mutazioni gene proteasi: Synonyms: Gene di proteasi dell''HIV Mutazioni nei geni di proteasi dell''HIV Punto nel tempo (episodio) Set di prescrizione per suscettibilità Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | HIV protease gen mutaties: |
| pt-BR | Portuguese (Brazil) | HIV protease mutações do gene: Synonyms: ; |
| zh-CN | Chinese (China) | HIV 蛋白酶基因突变: Synonyms: AIDS 病毒朊酶基因突变; |
30296-8 Amprenavir [Susceptibility] by Phenotype method
Part Descriptions
LP21307-1 Amprenavir
Amprenavir (Agenerase, GlaxoSmithKline) is a protease inhibitor used to treat HIV infection. Production of amprenavir was discontinued by the manufacturer December 31, 2004; a prodrug version (fosamprenavir) is available.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Amprenavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Amprenavir Islt Phenotyp
- Display Name
- Amprenavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Amprenavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.19
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41252-4 | AmprenavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Amprenavir: |
| es-AR | Spanish (Argentina) | amprenavir: |
| es-ES | Spanish (Spain) | Amprenavir: |
| et-EE | Estonian (Estonia) | Amprenaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Amprénavir: |
| fr-FR | French (France) | Amprénavir: |
| fr-BE | French (Belgium) | Amprénavir: |
| it-IT | Italian (Italy) | Amprenavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | Amprenavir: |
| nl-NL | Dutch (Netherlands) | amprenavir: |
| pt-BR | Portuguese (Brazil) | Amprenavir: Synonyms: Amp; |
| tr-TR | Turkish (Turkey) | Amprenavir: |
| zh-CN | Chinese (China) | 安普那韦: Synonyms: 分离物; |
49668-7 Atazanavir [Susceptibility] by Phenotype method
Part Descriptions
LP35785-2 Atazanavir
Atazanavir is an antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
LP35785-2 Atazanavir
Atazanavir, marketed under the trade name Reyataz is an antiretroviral drug of the protease inhibitor (PI) class. Like other antiretrovirals, it is used to treat infection of human immunodeficiency virus (HIV).
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Atazanavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Atazanavir Islt Phenotyp
- Display Name
- Atazanavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Atazanavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.22
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 17375
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41265-6 | AtazanavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Atazanavir: |
| es-MX | Spanish (Mexico) | Atazanavir: |
| es-ES | Spanish (Spain) | Atazanavir: |
| et-EE | Estonian (Estonia) | Atatsanaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Atazanavir: |
| fr-FR | French (France) | Atazanavir: |
| fr-BE | French (Belgium) | Atazanavir: |
| it-IT | Italian (Italy) | Atazanavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | atazanavir: |
| pt-BR | Portuguese (Brazil) | Atazanavir: Synonyms: ATV; |
| tr-TR | Turkish (Turkey) | Atazanavir: |
| zh-CN | Chinese (China) | 阿他那韦: Synonyms: 分离物; |
49666-1 Darunavir [Susceptibility] by Phenotype method
Part Descriptions
LP64724-5 Darunavir
Darunavir (Prezista) is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment-naïve and treatment-experienced adults and adolescents. Developed by pharmaceutical company Tibotec, darunavir is named after Arun K. Ghosh, the chemist who discovered the molecule at the University of Illinois in Chicago. It was approved by the Food and Drug Administration (FDA) on June 23, 2006.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Darunavir
LP64724-5 Darunavir
Darunavir (brand name Prezista, formerly known as TMC114) is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment-naïve and treatment-experienced adults and adolescents.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Darunavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Darunavir Islt Phenotyp
- Display Name
- Darunavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Darunavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.22
- Last Updated
- Version 2.22
- Order vs. Observation
- Both
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41328-2 | DarunavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Darunavir: |
| es-ES | Spanish (Spain) | Darunavir: |
| et-EE | Estonian (Estonia) | Darunaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Darunavir: |
| fr-FR | French (France) | Darunavir: |
| fr-BE | French (Belgium) | Darunavir: |
| it-IT | Italian (Italy) | Darunavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | darunavir: |
| pt-BR | Portuguese (Brazil) | Darunavir: Synonyms: Prezista; |
| tr-TR | Turkish (Turkey) | Darunavir: |
| zh-CN | Chinese (China) | 地瑞那韦: Synonyms: Darunavir; |
42500-9 Fosamprenavir [Susceptibility] by Phenotype method
Part Descriptions
LP36119-3 Fosamprenavir
Viral genomic sequencing is performed on patient plasma. Genomic mutations may occur, resulting in resistance to specific antiretroviral drugs. Fosamprenavir is an antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
LP36119-3 Fosamprenavir
Fosamprenavir is a pro-drug of the protease inhibitor and antiretroviral drug amprenavir.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Fosamprenavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Fosamprenavir Islt Phenotyp
- Display Name
- Fosamprenavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Fosamprenavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.16
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 16896
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41300-1 | FosamprenavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Fosamprenavir: |
| es-ES | Spanish (Spain) | Fosamprenavir: |
| et-EE | Estonian (Estonia) | Fosamprenaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Fosamprénavir: |
| fr-FR | French (France) | Fosamprénavir: |
| fr-BE | French (Belgium) | Fosamprénavir: |
| it-IT | Italian (Italy) | Fosamprenavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 포삼프레나비어: |
| nl-NL | Dutch (Netherlands) | fosamprenavir: |
| pt-BR | Portuguese (Brazil) | Fosamprenavir: Synonyms: FPV; |
| tr-TR | Turkish (Turkey) | Fosamprenavir: |
| zh-CN | Chinese (China) | 夫沙那韦: Synonyms: HIV 蛋白酶抑制剂; |
30278-6 Indinavir [Susceptibility] by Phenotype method
Part Descriptions
LP21311-3 Indinavir
A potent and specific HIV protease inhibitor that appears to have good oral bioavailability.
Source: National Library of Medicine, MeSH 2006
LP21311-3 Indinavir
Indinavir (IDV) is a protease inhibitor used as a component of highly active antiretroviral therapy (HAART) to treat HIV infection and AIDS.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Indinavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Indinavir Islt Phenotyp
- Display Name
- Indinavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Indinavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 17814
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41248-2 | IndinavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Indinavir: |
| es-AR | Spanish (Argentina) | indinavir: |
| es-ES | Spanish (Spain) | Indinavir: |
| et-EE | Estonian (Estonia) | Indinaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Indinavir: |
| fr-FR | French (France) | Indinavir: |
| fr-BE | French (Belgium) | Indinavir: |
| it-IT | Italian (Italy) | Indinavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | Indinavir: |
| nl-NL | Dutch (Netherlands) | indinavir: |
| pt-BR | Portuguese (Brazil) | Indinavir: Synonyms: Crixivan; |
| tr-TR | Turkish (Turkey) | Indinavir: |
| zh-CN | Chinese (China) | 茚地那韦: Synonyms: IDV; |
34643-7 Lopinavir [Susceptibility] by Phenotype method
Part Descriptions
LP28756-2 Lopinavir
Lopinavir (ABT-378) is an antiretroviral of the protease inhibitor class. It is marketed by Abbott as Kaletra (high-income countries) and Aluvia (low-income countries), both of which represent a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
LP28756-2 Lopinavir
Lopinavir (ABT-378) is an antiretroviral of the protease inhibitor class. It is used as a fixed-dose combination with another protease inhibitor, ritonavir, under the trade names Kaletra and Aluvia.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Lopinavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Lopinavir Islt Phenotyp
- Display Name
- Lopinavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Lopinavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.11
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 16253
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41217-7 | LopinavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Lopinavir: |
| es-AR | Spanish (Argentina) | lopinavir: |
| es-ES | Spanish (Spain) | Lopinavir: |
| et-EE | Estonian (Estonia) | Lopinaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Lopinavir: |
| fr-FR | French (France) | Lopinavir: |
| fr-BE | French (Belgium) | Lopinavir: |
| it-IT | Italian (Italy) | Lopinavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 로피나비르: |
| nl-NL | Dutch (Netherlands) | lopinavir: |
| pt-BR | Portuguese (Brazil) | Lopinavir: Synonyms: Kaletra; |
| tr-TR | Turkish (Turkey) | Lopinavir: |
| zh-CN | Chinese (China) | 洛匹那韦: Synonyms: LPV 分离物; |
30280-2 Nelfinavir [Susceptibility] by Phenotype method
Part Descriptions
LP21313-9 Nelfinavir
Nelfinavir (Viracept ®) is an antiretroviral drug used in the treatment of the human immunodeficiency virus (HIV). Nelfinavir belongs to the class of drugs known as protease inhibitors (PIs) and like other PIs is generally used in combination with other antiretroviral drugs. Nelfinavir is presented as the mesilate (mesylate) ester prodrug.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Nelfinavir (Wikipedia)
LP21313-9 Nelfinavir
Nelfinavir is a Protease Inhibitor (PI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Nelfinavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Nelfinavir Islt Phenotyp
- Display Name
- Nelfinavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Nelfinavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 19592
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41250-8 | NelfinavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Nelfinavir: |
| es-AR | Spanish (Argentina) | nelfinavir: |
| es-ES | Spanish (Spain) | Nelfinavir: |
| et-EE | Estonian (Estonia) | Nelfinaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Nelfinavir: |
| fr-FR | French (France) | Nelfinavir: |
| fr-BE | French (Belgium) | Nelfinavir: |
| it-IT | Italian (Italy) | Nelfinavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | Nelfinavir: |
| nl-NL | Dutch (Netherlands) | Nelfinavir: |
| pt-BR | Portuguese (Brazil) | Nelfinavir: Synonyms: Viracept; |
| tr-TR | Turkish (Turkey) | Nelfinavir: |
| zh-CN | Chinese (China) | 奈非那韦: Synonyms: NFV 分离物; |
30279-4 Ritonavir [Susceptibility] by Phenotype method
Part Descriptions
LP21314-7 Ritonavir
Ritonavir, with trade name Norvir® (Abbott Laboratories), is an antiretroviral drug from the protease inhibitor class used to treat HIV infection and AIDS. Ritonavir is frequently prescribed as the protease inhibitor component in HAART because it inhibits the same host enzyme that metabolizes NRTIs and NNRTIs. This inhibition leads to higher plasma concentrations of these latter drugs, allowing the clinician to lower their dose and frequency.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Ritonavir (Wikipedia)
LP21314-7 Ritonavir
Viral genomic sequencing is performed on patient plasma. Genomic mutations may occur, resulting in resistance to specific antiretroviral drugs. Ritonavir is a Protease Inhibitor (PI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Ritonavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Ritonavir Islt Phenotyp
- Display Name
- Ritonavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Ritonavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.19
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41249-0 | RitonavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Ritonavir: |
| es-MX | Spanish (Mexico) | Ritonavir: |
| es-AR | Spanish (Argentina) | ritonavir: |
| es-ES | Spanish (Spain) | Ritonavir: |
| et-EE | Estonian (Estonia) | Ritonaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Ritonavir: |
| fr-FR | French (France) | Ritonavir: |
| fr-BE | French (Belgium) | Ritonavir: |
| it-IT | Italian (Italy) | Ritonavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 리토나비어: |
| nl-NL | Dutch (Netherlands) | ritonavir: |
| pt-BR | Portuguese (Brazil) | Ritonavir: Synonyms: Norvir; |
| tr-TR | Turkish (Turkey) | Ritonavir: |
| zh-CN | Chinese (China) | 利托那韦: Synonyms: RTV; |
30281-0 Saquinavir [Susceptibility] by Phenotype method
Part Descriptions
LP14466-4 Saquinavir
Saquinavir is a Protease Inhibitor (PI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
LP14466-4 Saquinavir
Saquinavir is an antiretroviral drug used in HIV therapy. It falls in the protease inhibitor class.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Saquinavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Saquinavir Islt Phenotyp
- Display Name
- Saquinavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Saquinavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.19
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41251-6 | SaquinavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Saquinavir: |
| es-AR | Spanish (Argentina) | saquinavir: |
| es-ES | Spanish (Spain) | Saquinavir: |
| fr-CA | French (Canada) | Saquinavir: |
| fr-FR | French (France) | Saquinavir: |
| fr-BE | French (Belgium) | Saquinavir: |
| it-IT | Italian (Italy) | Saquinavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 사퀴나비르: |
| nl-NL | Dutch (Netherlands) | saquinavir: |
| pt-BR | Portuguese (Brazil) | Saquinavir: Synonyms: Fortovase; |
| tr-TR | Turkish (Turkey) | Sakuinavir: |
| zh-CN | Chinese (China) | 沙奎那韦: Synonyms: SQV 分离物; |
49667-9 Tipranavir [Susceptibility] by Phenotype method
Part Descriptions
LP36120-1 Tipranavir
anti-viral drug
Source: Regenstrief Institute
LP36120-1 Tipranavir
Tipranavir, or tipranavir disodium, is a nonpeptidic protease inhibitor (PI) manufactured by Boehringer-Ingelheim under the trade name Aptivus. It is administered with ritonavir in combination therapy to treat HIV infection.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Tipranavir
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Short Name
- Tipranavir Islt Phenotyp
- Display Name
- Tipranavir Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Tipranavir
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.22
- Last Updated
- Version 2.22
- Order vs. Observation
- Both
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41329-0 | TipranavirSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Tipranavir: |
| es-ES | Spanish (Spain) | Tipranavir: |
| et-EE | Estonian (Estonia) | Tipranaviir: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-CA | French (Canada) | Tipranavir: |
| fr-FR | French (France) | Tipranavir: |
| fr-BE | French (Belgium) | Tipranavir: |
| it-IT | Italian (Italy) | Tipranavir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | tipranavir: |
| pt-BR | Portuguese (Brazil) | Tipranavir: Synonyms: TPV; |
| tr-TR | Turkish (Turkey) | Tipranavir: |
| zh-CN | Chinese (China) | 替拉那韦: Synonyms: 分离物; |